Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Non-Current Debt: 2019-2020

  • Genmab A's Non-Current Debt rose 31.12% to $41.6 million in Q4 2020 from the same period last year, while for Dec 2020 it was $41.6 million, marking a year-over-year increase of 31.12%. This contributed to the annual value of $41.6 million for FY2020, which is 31.12% up from last year.
  • Latest data reveals that Genmab A reported Non-Current Debt of $41.6 million as of Q4 2020, which was up 31.12% from $31.7 million recorded in Q4 2019.
  • Genmab A's 5-year Non-Current Debt high stood at $7,614.5 billion for Q4 2020, and its period low was $7,614.5 billion during Q4 2020.
  • In the last 2 years, Genmab A's Non-Current Debt had a median value of $36.7 million in 2019 and averaged $36.7 million.
  • Data for Genmab A's Non-Current Debt shows a peak YoY skyrocketed of 31.12% (in 2020) over the last 5 years.
  • Genmab A's Non-Current Debt (Quarterly) stood at $31.7 million in 2019, then soared by 31.12% to $41.6 million in 2020.